Global Medical Imaging Systems Market Size, Share & Forecast, By Product Type, Care Setting & Technology, 2025-2032

The Global Medical Imaging Systems Market is worth USD 62 billion in 2025 under the report's manufacturer-level scope. The scope includes CT, MRI, ultrasound, radiography, mammography, angiography, image-guided therapy and nuclear imaging equipment together with attached OEM service revenue. It excludes hospital scan-fee revenue, radiotherapy, IVD, patient monitoring, contrast media and radiopharmaceuticals. The broader scope explains why this estimate is above syndicated equipment-only estimates clustered primarily between USD 44 billion and USD 52 billion.

The market is projected to reach approximately USD 95 billion by 2032, representing a 6.20% CAGR from the 2025 base. Value growth is expected to outpace physical system shipments because AI-enabled software, higher-specification CT and MRI systems, image-guided therapy and lifecycle service increase revenue per installed system. The modeled system-volume CAGR remains close to 3%, meaning a material portion of incremental revenue is generated by product mix and recurring commercial attachment rather than unit expansion alone.

Profit pools are shifting toward premium CT and MRI, image-guided therapy, AI software and recurring lifecycle services. Hardware remains the industry's largest revenue foundation, but software and service offer stronger recurring economics and deepen customer switching costs. The report models service and software at approximately 32% of 2025 revenue, increasing through the forecast horizon. Siemens Healthineers' FY2025 Imaging adjusted EBIT margin of 20.6% demonstrates the earnings quality that differentiated imaging portfolios can generate at scale.

The principal risk is sustained pricing and procurement pressure, particularly in China, combined with rising regulatory costs for connected and AI-enabled platforms. Mindray reported a 9.4% decline in total 2025 revenue and approximately 18% contraction in Medical Imaging Products, highlighting sensitivity to hospital capital budgets. At the same time, EU MDR, EUDAMED and evolving AI rules increase compliance requirements. These pressures can reduce realized ASP growth even where underlying diagnostic demand remains structurally strong.

North America remains the largest near-term profit pool, while Asia Pacific offers the strongest capacity-growth opportunity. North America benefits from premium modality penetration, high scanner utilization and established service economics. Asia Pacific combines large patient populations, hospital infrastructure expansion and increasingly capable domestic manufacturers. The report models Asia Pacific at an 8.0% CAGR through 2032, above North America and Europe. This creates different strategies: premium installed-base monetization in mature markets and capacity plus localization strategies in faster-growth Asian markets.

The most durable demand factor is the combination of high imaging utilization and recurring replacement of installed systems. Approximately 3.6 billion diagnostic imaging examinations are performed globally each year, while CT, MRI and other advanced scanners operate within finite technology and maintenance lifecycles. Screening expansion, aging populations and chronic-disease diagnosis increase utilization, while older systems are replaced with higher-throughput and software-rich platforms. This creates a dual growth mechanism of more imaging capacity and higher commercial value per replacement system.